| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.7 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.031 | 0.7 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |